Cutler Group’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

Cutler Group’s Portfolio DMK Stock Details DMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-639	Closed	-$18K	–	4758
2018 Q3	$18K	Buy	+639	New	+$151K	﹤0.01%	2319
2018 Q2	–	Sell	-24	Closed	-$1K	–	5078
2018 Q1	$1K	Buy	24 +10	+71%	+$2.63K	﹤0.01%	4228
2017 Q4	$1K	Sell	14 -72	-84%	-$23.7K	﹤0.01%	4652
2017 Q3	$3K	Sell	86 -163	-65%	-$57.8K	﹤0.01%	4903
2017 Q2	$7K	Buy	249 +206	+479%	+$61.7K	﹤0.01%	4584
2017 Q1	$1K	Sell	43 -71	-62%	-$17.9K	﹤0.01%	6064
2016 Q4	$1K	Sell	114 -72	-39%	-$14.4K	﹤0.01%	6218
2016 Q3	$4K	Buy	186 +110	+145%	+$22.9K	﹤0.01%	5223
2016 Q2	$1K	Buy	+76	New	+$35K	﹤0.01%	6344

Other funds holding DMK

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return

Cutler Group's DMK Position: Q1 2019 in Review

Cutler Group sold out of DMK Pharmaceuticals Corporation Common Stock (DMK) in Q1 2019, closing a stake of 92 shares — an estimated $14K sold.

Cutler Group first reported a position in DMK in Q1 2016 and held it in 12 quarters. The position peaked at $24K in Q3 2018. 57 funds tracked by Wall St. Rank hold DMK as of Q1 2019.

Cutler Group reported no remaining DMK Pharmaceuticals Corporation Common Stock position as of Q1 2019 after selling out during the quarter.
Cutler Group sold 92 DMK Pharmaceuticals Corporation Common Stock shares in Q1 2019, an estimated $14K.
Cutler Group first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q1 2016 and held it in 12 quarters.
Cutler Group's DMK Pharmaceuticals Corporation Common Stock position peaked at $24K in Q3 2018.
57 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q1 2019.

Based on Cutler Group's 13F filing for Q1 2019, filed 10 May 2019.